D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
AT&T
T
|
+$518M |
| 2 |
Booking.com
BKNG
|
+$474M |
| 3 |
Qualcomm
QCOM
|
+$436M |
| 4 |
Chevron
CVX
|
+$270M |
| 5 |
Meta Platforms (Facebook)
META
|
+$203M |
Top Sells
| 1 |
Apple
AAPL
|
+$990M |
| 2 |
Netflix
NFLX
|
+$315M |
| 3 |
Johnson & Johnson
JNJ
|
+$254M |
| 4 |
McDonald's
MCD
|
+$252M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$223M |
Sector Composition
| 1 | Technology | 18.97% |
| 2 | Consumer Discretionary | 16.19% |
| 3 | Healthcare | 13.32% |
| 4 | Financials | 11.3% |
| 5 | Industrials | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Macerich
MAC
$4.58B
| $1.35M | ﹤0.01% |
+24,432
| New | +$1.35M |
|
1652
Corpay
CPAY
$21.7B
| $1.35M | ﹤0.01% |
5,911
+2,715
| +85% | +$619K |
|
1653
Snap-on
SNA
$17.4B
| $1.34M | ﹤0.01% |
7,282
+1,076
| +17% | +$198K |
|
1654
Ardelyx
ARDX
$1.59B
| $1.34M | ﹤0.01% |
307,159
+73,044
| +31% | +$318K |
|
|
GHL
1655
DELISTED
Greenhill & Co., Inc.
GHL
| $1.34M | ﹤0.01% |
50,721
-33,978
| -40% | -$895K |
|
1656
First Merchants
FRME
$2.31B
| $1.33M | ﹤0.01% |
29,642
-26,356
| -47% | -$1.19M |
|
1657
Merchants Bancorp
MBIN
$1.5B
| $1.33M | ﹤0.01% |
78,747
+9,961
| +14% | +$169K |
|
|
BLUE
1658
DELISTED
bluebird bio
BLUE
| $1.33M | ﹤0.01% |
+705
| New | +$1.33M |
|
1659
Digimarc
DMRC
$204M
| $1.33M | ﹤0.01% |
42,319
+7,647
| +22% | +$241K |
|
|
ECYT
1660
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $1.33M | ﹤0.01% |
74,788
-602,215
| -89% | -$10.7M |
|
1661
Kimco Realty
KIM
$15.2B
| $1.33M | ﹤0.01% |
79,287
+15,611
| +25% | +$261K |
|
1662
Greif
GEF
$3.59B
| $1.32M | ﹤0.01% |
24,650
-1,372
| -5% | -$73.6K |
|
1663
Natural Health Trends
NHTC
$53.9M
| $1.31M | ﹤0.01% |
56,408
+10,704
| +23% | +$249K |
|
1664
Q2 Holdings
QTWO
$5.13B
| $1.31M | ﹤0.01% |
21,690
+14,696
| +210% | +$890K |
|
1665
Arrowhead Research
ARWR
$4.11B
| $1.31M | ﹤0.01% |
68,257
-45,652
| -40% | -$875K |
|
|
B
1666
DELISTED
Barnes Group Inc.
B
| $1.31M | ﹤0.01% |
18,429
-36,916
| -67% | -$2.62M |
|
1667
Cantaloupe
CTLP
$792M
| $1.31M | ﹤0.01% |
+181,720
| New | +$1.31M |
|
1668
United Natural Foods
UNFI
$1.77B
| $1.31M | ﹤0.01% |
43,680
+18,584
| +74% | +$556K |
|
1669
Astronics
ATRO
$1.41B
| $1.3M | ﹤0.01% |
34,334
+3,216
| +10% | +$122K |
|
1670
Core Laboratories
CLB
$581M
| $1.3M | ﹤0.01% |
+11,203
| New | +$1.3M |
|
|
CSLT
1671
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.3M | ﹤0.01% |
480,762
-145,252
| -23% | -$392K |
|
|
FOMX
1672
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.3M | ﹤0.01% |
226,010
+172,248
| +320% | +$988K |
|
|
RYAM.PRA
1673
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
| $1.29M | ﹤0.01% |
10,000
| – | – |
|
1674
Qorvo
QRVO
$8.04B
| $1.29M | ﹤0.01% |
16,752
-579
| -3% | -$44.5K |
|
1675
Columbia Banking Systems
COLB
$7.8B
| $1.29M | ﹤0.01% |
33,182
-5,200
| -14% | -$202K |
|